|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | The American Heart Association’s Get With the Guidelines(GWTG)-Stroke development and impact on stroke care显示文摘The American Heart Association’s Get With the Guidelines(GWTG)-Stroke programme has changed stroke care delivery in the USA since its establishment in 2003.GWTG is a voluntary registry and continuous quality improvement initiative that collects data on patient characteristics,hospital adherence to guidelines and inpatient outcomes.Implementation of the programme saw increased provision of evidence-based care and improved patient outcomes.This review will describe the development of the programme and discuss the impact on stroke outcomes and transformation of stroke care delivery that followed its implementation. | Cora H Ormseth Kevin N Sheth Jeffrey L Saver Gregg C Fonarow Lee H Schwamm | 2017 | Stroke & Vascular Neurology2017，2，2： | 15 |
| 2 | Outcomes of Medicare beneficiaries hospitalised with transient ischaemic attack and stratification using the ABCD^(2) score显示文摘Background Long-term outcomes for Medicare beneficiaries hospitalised with transient ischaemic attack(TIA)and role of ABCD^(2) score in identifying high-risk individuals are not studied.Methods We identified 40825 Medicare beneficiaries hospitalised from 2011 to 2014 for a TIA to a Get With The Guidelines(GWTG)-Stroke hospital and classified them using ABCD^(2)s of mortality and rehospitalisation(all-cause,ischaemic stroke,haemorrhagic stroke,myocardial infarction,and gastrointestinal and intracranial haemorrhage)for high-risk versus low-risk groups adjusted for patient and hospital characteristics.Results Of the 40825 patients,35118(86%)were high risk(ABCD^(2)≥4)and 5707(14%)were low risk(ABCD^(2)=0-3).Overall rate of mortality during 1-year follow-up after hospital discharge for the index TIA was 11.7%,44.3% were rehospitalised for any reason and 3.6%were readmitted due to stroke.Patients with ABCD^(2) score≥4 had higher mortality at 1 year than not(adjusted HR 1.18,95%CI 1.07 to 1.30).Adjusted risks for ischaemic stroke,all-cause readmission and mortality/all-cause readmission at 1 year were also significantly higher for patients with ABCD^(2) score≥4 vs 0-3.In contrast,haemorrhagic stroke,myocardial infarction,gastrointestinal bleeding and intracranial haemorrhage risk were not significantly different by ABCD^(2) score.Conclusions This study validates the use of ABCD^(2) score for long-term risk assessment after TIA in patients aged 65 years and older.Attentive efforts for community-based follow-up care after TIA are needed for ongoing prevention in Medicare beneficiaries who were hospitalised for TIA. | Shreyansh Shah Li Liang Durgesh Bhandary Saga Johansson Eric E Smith Deepak L Bhatt Gregg C Fonarow Naeem D Khan Eric Peterson Janet Prvu Bettger | 2021 | Stroke & Vascular Neurology2021，6，2： | 3 |
| 3 | Statin therapy is associated with improved survival in ischemic and non-ischemic heart failure显示文摘 | Tamara B Horwich W.Robb MacLellan Gregg C Fonarow | 2004 | Journal of the American College of Cardiology2004，，4： | 3 |
| 4 | The dissociation between door-to-balloon time improvement and improvements in other acute myo- cardial infarction care processes and patient outcomes 显示文摘 | WANG T Y FONAROW G C HERNANDEZ A F | 2009 | Arch InternMed2009，169，： | 1 |
| 5 | Randomized clinical outcome trials of statins in heart failure 显示文摘 | FONAROW G C | 2008 | Heart Fail Clin2008，4，2： | 1 |
| 6 | Epidemiology and risk profile of heart failure显示文摘 | Bui AL Horwich TB Fonarow G C | 2011 | Nat Rev Cardio2011，8，1： | 1 |
| 7 | Cholesterol and mortality in heart failure:the bad gone good显示文摘 | Fonarow G C Horwich T B | | 0，，11： | 1 |
| 8 | Treating to goal: new strategies for initiating and optimizing lipid-lowering therapy in patients with atherosclerosis 显示文摘 | Fonarow G C | 2002 | Vasc Med2002，7，3： | 1 |
| 9 | Development of stroke performance measures:definitions, methods, and current measures显示文摘 | Reeves M J Parker C Fonarow GC | 2010 | Stroke2010，41，： | 1 |
| 10 | Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP)显示文摘 | Fonarow G C Gawlinski A Moughrabi S | 2001 | Am J Cardiol2001，87，7： | 1 |
| 11 | Interleukin - 6 (IL- 6)expression and natural killer (NK) cell dysfunction and anergy in heart failure显示文摘 | VREDEVOE D L WIDAWSKI M FONAROW G C | 2004 | Am J Cardiol2004，93，8： | 1 |
| 12 | Depression in patients with heart failure 显示文摘 | Westlake C Dracup K Fonarow G | 2005 | J Card Fail2005，11，1： | 1 |
| 13 | Improved treatment of coronary heart disease by implementatiou of a cardiac hospitalization atherosclerosis management program ( CHAMP ) 显示文摘 | Fonarow C C Gawlinski A Moughrabi S | 2001 | Am J Cardiol2001，87，： | 1 |
| 14 | Epidemiology and risk profile of heart failure显示文摘 | Bui A L Horwich T B Fonarow G C | | 0，，1： | 1 |
| 15 | Statin therapy is associated with improved survival in ischemic and non ischemic heart failure显示文摘 | HORWICH T B MACLELLAN W R FONAROW G C | 2004 | J Am Coll Cardiol2004，43，4： | 1 |
| 16 | 冠心病和其他动脉粥样硬化性血管疾病二级预防指南:2006年版(摘要)显示文摘美国心脏学会(American College of Cardiology,ACC)与美国心脏病协会(American Heart Association.AHA)关于二级预防的共识声明自2001年更新以来,许多临床试验提供了重要证据.进一步支持和拓展了对冠心病和其他动脉粥样硬化性血管疾病(包括外周动脉疾病、动脉粥样硬化性主动脉疾病和颈动脉疾病)进行积极控制危险因素治疗的重要性。证据不断涌现,证实对这些患者进行积极而全面的危险因素干预治疗能够改善生存率,减少事件复发以及对介入治疗的需要.并提高生活质量。 | SMITH S C ALLEN J BLAIR S N BONOW R O BRASS L M FONAROW G C GRUNDY S M HIRATZKA L JONES D KRUMHOLZ H M MOSCA L PASTERNAK R C PEARSON T PFEFFER M A TAUBERT K A | 2008 | 岭南心血管病杂志2008，14，2： | 1 |
| 17 | Characteristics,treatments,and outcomes of patients with preserved systolic function hospitalized for heart failure:a report from the OPTIMIZE-HF Registry显示文摘 | FONAROW G C STOUGH W G ABRAHAM W T | 2007 | J Am Coil Cardiol2007，50，8： | 1 |
| 18 | Depression in patients with heart failure显示文摘 | Westlake C Dracup K Fonarow G | 2005 | J Cardiac Fail2005，11，1： | 1 |
| 19 | Total cholesterol levels and mortality risk in nonischemic systolic heart failure 显示文摘 | Afsarmanesh N Horrwich T B Fonarow G C | 2006 | Am Heart J2006，152，6： | 1 |
| 20 | Association between performance measures and clinical outcomes for patients hospitalized with heart failure显示文摘 | FONAROW G C ABRAHAM W T ALBERT N M | 2007 | JAMA2007，297，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员